Download PDF
Journal of Pediatric Neurology 2015; 13(03): 110-115
DOI: 10.1055/s-0035-1557148
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Neurophysiologic Evaluation of Children with Beta-Thalassemia Major

Hanan G. Azouz
1   Department of Pediatric Neurology, Faculty of Medicine, Alexandria University, Egypt
,
Hoda M. A. Hassab
2   Department of Pediatric Hematology, Faculty of Medicine, Alexandria University, Egypt
,
Hayam M. Abd Elghany
3   Department of Physical Medicine, Rheumatology Rehabilitation Faculty of Medicine, Alexandria University, Egypt
,
Marwa A. Abdallah
1   Department of Pediatric Neurology, Faculty of Medicine, Alexandria University, Egypt
› Author Affiliations
Further Information

Publication History

20 December 2014

19 May 2015

Publication Date:
07 August 2015 (online)

    Permissions and Reprints

Abstract

Neural pathway involvement is considered to be a neurological complication in Beta-thalassemia major (BTM). This study aimed to detect possible involvement of central and peripheral neural pathways in a group of neurologically asymptomatic patients with BTM. It was performed on 30 patients diagnosed as having BTM (group I), and 10 healthy children who were matched for age, sex, and height (group II). Serum ferritin, iron, glucose tolerance test, intelligence quotient (IQ) test, and electroencephalogram (EEG) were assessed in BTM patients. Electrophysiologic study was assessed in both groups. The mean age of the patients was 10.45 ± 2.88 years. They were 14 males and 16 females. The results of the present study showed that 66.7% of patients had subclinical sensory peripheral neuropathy. Twenty percent of the patients had abnormal somatosensory evoked potentials. Low average and slow learner total IQ score were found in 63.3% of the studied patients. These findings did not correlate with age, disease duration, serum iron, and ferritin. Twenty-three patients had mature EEG background activity, while seven patients had immature background activity. The EEG background maturity had significant correlation with age, duration of desferrioxamine therapy, and serum iron. There was no correlation between serum ferritin level, EEG, and electrophysiologic findings. Regular electrophysiologic monitoring and intellectual evaluation are recommended to detect relevant abnormalities and apply appropriate management.

Keywords

beta-thalassemia major - electrophysiologic study - peripheral neuropathy - intelligence quotient test - electroencephalogram

Financial Support

None.


 

  • References

  • 1 Shamshirsaz AA, Bekheirnia MR, Kamgar M , et al. Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran. BMC Endocr Disord 2003; 3 (1) 4
    CrossrefPubMedGoogle Scholar
  • 2 Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis 2010; 5: 11
    CrossrefPubMedGoogle Scholar
  • 3 Zafeiriou DI, Economou M, Athanasiou-Metaxa M. Neurological complications in β-thalassemia. Brain Dev 2006; 28 (8) 477-481
    CrossrefPubMedGoogle Scholar
  • 4 Logothetis J, Constantoulakis M, Economidou J , et al. Thalassemia major (homozygous β-thalassemia). A survey of 138 cases with emphasis on neurologic and muscular aspects. Neurology 1972; 22 (3) 294-304
    CrossrefPubMedGoogle Scholar
  • 5 Sinniah D, Vignaendra V, Ahmad K. Neurological complications of beta-thalassaemia major. Arch Dis Child 1977; 52 (12) 977-979
    CrossrefPubMedGoogle Scholar
  • 6 Papanastasiou DA, Papanicolaou D, Magiakou A-M, Beratis NG, Tzebelikos E, Papapetropoulos T. Peripheral neuropathy in patients with beta-thalassaemia. J Neurol Neurosurg Psychiatry 1991; 54 (11) 997-1000
    CrossrefPubMedGoogle Scholar
  • 7 Ogilvie C, Fitzsimons K, Fitzsimons EJ. Serum ferritin values in primary care: are high values overlooked?. J Clin Pathol 2010; 63 (12) 1124-1126
    CrossrefPubMedGoogle Scholar
  • 8 Cook JD, Flowers CH, Skikne BS. The quantitative assessment of body iron. Blood 2003; 101 (9) 3359-3364
    CrossrefPubMedGoogle Scholar
  • 9 Fischbach FT, Dunning III MB , Eds. Manual of Laboratory and Diagnostic Tests, 8th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2009
    Google Scholar
  • 10 American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012; 35 (Suppl. 01) S64-S71
    CrossrefPubMedGoogle Scholar
  • 11 Preston DC, Shapiro BE , eds. Electromyography and Neuromuscular Disorders: Clinical-Electrophysiologic Correlations (expert consult - online). UK: Elsevier Health Sciences; 2012
    Google Scholar
  • 12 Delisa JA, Lee HJ, Baran EM, Lai KS, Spielholz N. Somatosensory evoked potentials. In: DeLisa JA, , ed. Manual of Nerve Conduction Velocity and Clinical Neurophysiology. 3rd ed. New York: Raven; 1994: 195-207
    Google Scholar
  • 13 Melika LK. The Stanford Binet intelligent scale. Arabic Examiner Handbook, 4th ed. Cairo, Egypt: Dar El Maaref Publishing; 1998
    Google Scholar
  • 14 Teplan M. Fundamentals of EEG measurement 3 measurement science. Meas Sci Rev 2002; 2 (2) 1-10
    PubMedGoogle Scholar
  • 15 Moorjani JD, Issac C. Neurotic manifestations in adolescents with thalassemia major. Indian J Pediatr 2006; 73 (7) 603-607
    CrossrefPubMedGoogle Scholar
  • 16 Papanastasiou DA, Papanicolaou D, Magiakou AM , et al. Peripheral neuropathy in patients with betathalassaemia. J Neurol Neurosurg Psychiatry 1991; 54 (11) 997-1000
    CrossrefPubMedGoogle Scholar
  • 17 Lamabadusuriya SP. Multiple nerve palsies in beta thalassaemia major. Arch Dis Child 1989; 64 (7) 1060-1061
    CrossrefPubMedGoogle Scholar
  • 18 Olivieri NF, Buncic JR, Chew E , et al. Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions. N Engl J Med 1986; 314 (14) 869-873
    CrossrefPubMedGoogle Scholar
  • 19 Duman O, Arayici S, Fettahoglu C , et al. Neurocognitive function in patients with β-thalassemia major. Pediatr Int 2011; 53 (4) 519-523
    CrossrefPubMedGoogle Scholar
  • 20 Sawaya RA, Zahed L, Taher A. Peripheral neuropathy in thalassaemia. Ann Saudi Med 2006; 26 (5) 358-363
    PubMedGoogle Scholar
  • 21 Stamboulis E, Vlachou N, Drossou-Servou M , et al. Axonal sensorimotor neuropathy in patients with beta-thalassaemia. J Neurol Neurosurg Psychiatry 2004; 75 (10) 1483-1486
    CrossrefPubMedGoogle Scholar
  • 22 Wong V, Li A, Lee AC. Neurophysiologic study of beta-thalassemia patients. J Child Neurol 1993; 8 (4) 330-335
    CrossrefPubMedGoogle Scholar
  • 23 Zafeiriou DI, Kousi AA, Tsantali CT , et al. Neurophysiologic evaluation of long-term desferrioxamine therapy in beta-thalassemia patients. Pediatr Neurol 1998; 18 (5) 420-424
    CrossrefPubMedGoogle Scholar
  • 24 Teunissen LL, Notermans NC, Wokke JHJ. Relationship between ischemia and neuropathy. Eur Neurol 2000; 44 (1) 1-7
    CrossrefPubMedGoogle Scholar
  • 25 Nowak D, Brüch M, Arnaud F , et al. Peripheral neuropathies in patients with chronic obstructive pulmonary disease: a multicenter prevalence study. Lung 1990; 168 (1) 43-51
    PubMedGoogle Scholar
  • 26 Ozge A, Atiş S, Sevim S. Subclinical peripheral neuropathy associated with chronic obstructive pulmonary disease. Electromyogr Clin Neurophysiol 2001; 41 (3) 185-191
    PubMedGoogle Scholar
  • 27 Yiannikas C, McLeod JG, Walsh JC. Peripheral neuropathy associated with polycythemia vera. Neurology 1983; 33 (2) 139-143
    CrossrefPubMedGoogle Scholar
  • 28 Poza JJ, Cobo AM, Martí-Massó JF. Peripheral neuropathy associated with polycythemia vera. Neurologia 1996; 11 (8) 276-279
    PubMedGoogle Scholar
  • 29 England JD, Regensteiner JG, Ringel SP, Carry MR, Hiatt WR. Muscle denervation in peripheral arterial disease. Neurology 1992; 42 (5) 994-999
    CrossrefPubMedGoogle Scholar
  • 30 Stamboulis EJ, Syrigou-Papavasiliou A, Platokouki HG, Mitsika AP, Aronis SA. Subclinical neuropathy in children with inherited haemostasis disorders. Electromyogr Clin Neurophysiol 1992; 32 (10-11) 511-514
    PubMedGoogle Scholar
  • 31 Vichinsky E, Onyekwere O, Porter J , et al. A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease. Br J Haematol 2007; 136 (3) 501-508
    CrossrefPubMedGoogle Scholar
  • 32 McDonagh K, Nieuhuis A. The thalassemias. In: Nathan DG, Oski FA, , eds. Hematology of Infancy and Childhood. 4th ed. Philadelphia, PA: WB Saunders; 1993: 674-695
    Google Scholar
  • 33 Economou M, Zafeiriou DI, Kontopoulos E , et al. Neurophysiologic and intellectual evaluation of beta-thalassemia patients. Brain Dev 2006; 28 (1) 14-18
    CrossrefPubMedGoogle Scholar
  • 34 Ambrosetti U, Dondè E, Piatti G, Cappellini MD. Audiological evaluation in adult beta-thalassemia major patients under regular chelation treatment. Pharmacol Res 2000; 42 (5) 485-487
    CrossrefPubMedGoogle Scholar
  • 35 Duman O, Arayici S, Fettahoglu C , et al. Neurocognitive function in patients with ßthalassemia major. Pediatr Int 2011; 53 (4) 519-523
    CrossrefPubMedGoogle Scholar
  • 36 Triantafyllou NI, Anthracopoulos M, Zalonis I , et al. Cognition in homozygous beta-thalassemia disease: a multichannel auditory event-related potential (P300) study. Electromyogr Clin Neurophysiol 1992; 32 (10-11) 531-535
    PubMedGoogle Scholar
  • 37 Monastero R, Monastero G, Ciaccio C, Padovani A, Camarda R. Cognitive deficits in beta-thalassemia major. Acta Neurol Scand 2000; 102 (3) 162-168
    PubMedGoogle Scholar
  • 38 Khairkar P, Malhotra S, Marwaha R. Growing up with the families of β-thalassaemia major using an accelerated longitudinal design. Indian J Med Res 2010; 132: 428-437
    PubMedGoogle Scholar
  • 39 Nemtsas P, Arnaoutoglou M, Perifanis V, Koutsouraki E, Orologas A. Neurological complications of beta-thalassemia. Ann Hematol 2015;
    PubMedGoogle Scholar
  • 40 Nemtsas P, Perifanis V, Koutsouraki E, Orologas A, Arnaoutoglou M. is precautionary neurophysiological monitoring useful for beta-thalassemia patients?. Clin Neurophysiol 2014; 125 (Suppl. 01) S219
    PubMedGoogle Scholar